GSK: license for experimental treatment for hepatitis B

GSK: Success of a trial in endometrial cancer

GSK: invests 350 ME in its Evreux site

GSK: EU authorization for HIV prevention

GSK: Ojjaara has been approved by the FDA

GSK: renews its partnership with Save the Children

GSK: Arexvy anti-RSV vaccine marketed in the USA